Stephen DeWilde

Stephen DeWilde

Auto-generated profile, based on publicly available information

Stephen DeWilde

Population Health Research Institute, St George's University of London, London, UK

Research Focus & Metrics

Academic Career Length

27Years (2000-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 August 2016 in American Journal of Public Health
Verified
Journal Article
Closed access
FHFay J. Hosking
Fay J. Hosking
ICIain M. Carey
Iain M. Carey
SSSunil M. Shah
Sunil M. Shah
THTess Harris
Tess Harris
SDStephen DeWilde
Stephen DeWilde
DCDerek G. Cook
Derek G. Cook
Objectives. To describe mortality among adults with intellectual disability in England in comparison with the general population.Methods. We conducted a cohort study from 2009 to 2013 using data from 343 general practices. Adults with intellectual disability (n = 16 666; 656 deaths) were compared with age-, gender-, and practice-matched controls (n = 113 562; 1358 deaths).Results. Adults with intellectual disability had higher mortality rates than controls (hazard ratio [HR] = 3.6; 95% confidence interval [CI] = 3.3, 3.9). This risk remained high after adjustment for comorbidity, smoking, and deprivation (HR = 3.1; 95% CI = 2.7, 3.4); it was even higher among adults with intellectual disability and Down syndrome or epilepsy. A total of 37.0% of all deaths among adults with intellectual disability were classified as being amenable to health care intervention, compared with 22.5% in the general population (HR = 5.9; 95% CI = 5.1, 6.8).Conclusions. Mortality among adults with intellectual disability is markedly elevated in comparison with the general population, with more than a third of deaths potentially amenable to health care interventions. This mortality disparity suggests the need to improve access to, and quality of, health care among people with intellectual disability.

1 April 2014 in JAMA Internal Medicine
Verified
Journal Article
Open access
PDF file
ICIain M. Carey
Iain M. Carey
SSSunil M. Shah
Sunil M. Shah
SDStephen DeWilde
Stephen DeWilde
THTess Harris
Tess Harris
CVChristina R Victor
Christina R Victor
DCDerek G. Cook
Derek G. Cook
Bereavement has long been recognized as a risk factor for increased mortality, particularly from cardiovascular disease,1 with grief leading to potential adverse physiological responses.2 A large literature on the relationship between bereavement and mortality from numerous countries3,4 uses a range of data sources and methods that have consistently shown higher rates of mortality in bereaved individuals. These findings have been summarized in 2 recent meta-analyses,5,6 one of which estimated a 41% increase in mortality in the first 6 months after the death of a spouse.5 Specific associations with cardiovascular mortality have been found, although studies have generally lacked statistical power to produce precise estimates of the risk within the first few months.7,8 A recent case crossover analysis of patients hospitalized with myocardial infarction (MI) reported a striking 21-fold elevated risk of nonfatal MI within 24 hours of the death of a significant person,9 but few of these deaths represented partner bereavements.

1 May 2000 in Psychosomatic Medicine
Verified
Journal Article
Closed access
TRThomas Ritz
Thomas Ritz
ASAndrew Steptoe
Andrew Steptoe
SDStephen DeWilde
Stephen DeWilde
MCMarco Costa
Marco Costa
Clinical reports suggest that various emotions and types of stress can precipitate asthmatic symptoms, but there is little experimental evidence to substantiate this claim. We studied the impact of different emotional states and stress on respiratory resistance in asthmatic and nonasthmatic individuals. Participants (24 asthmatic and 24 nonasthmatic patients) viewed short film sequences selected to induce anxiety, anger, depression, elation, happiness, contentment, or a neutral affective state and completed two stressful tasks, mental arithmetic to induce active coping efforts and viewing of medical slides to induce passive coping efforts. Oscillatory resistance, heart rate, blood pressure, baroreflex sensitivity, skin conductance level, respiration rate and volume, and self-reported affective state were measured throughout the session. Uniform increases in oscillatory resistance were found in all emotional states compared with the neutral state and during mental arithmetic in both groups. Asthmatic patients showed stronger reactions to the medical slides than healthy control subjects, with significant increases in oscillatory resistance, blood pressure, skin conductance level, and minute volume, as well as higher levels of self-reported depression, arousal, and shortness of breath. Changes in oscillatory resistance were inconsistently correlated with other physiological indices. Various emotional states and stress increase oscillatory resistance largely independently of concurrent increases in autonomic or ventilatory activity. The particular sensitivity of asthmatics to passive coping demand requires additional research.

30 December 2005 in Heart
Verified
Journal Article
Open access
PDF file
SDS DeWilde
S DeWilde
ICI M Carey
I M Carey
CEC Emmas
C Emmas
NRN Richards
N Richards
DCD G Cook
D G Cook
Objectives: To examine trends in the prevalence of diagnosed atrial fibrillation (AF), its treatment with oral anticoagulants between 1994 and 2003, and predictors of anticoagulant treatment in 2003. Methods: Analysis of electronic data from 131 general practices (about one million registered patients annually) contributing to the DIN-LINK database. Results: From 1994 to 2003 the prevalence of “active” AF rose from 0.78% to 1.31% in men and from 0.79% to 1.15% in women. The proportion of patients with AF taking anticoagulants rose from 25% to 53% in men and from 21% to 40% in women. Most others received antiplatelets. The likelihood of receiving anticoagulants was greater for men and with increasing stroke risk. It decreased sharply with age after 75 years. Socioeconomic status, urbanisation and region had no influence. Non-steroidal anti-inflammatory drugs, antiplatelet drugs and ulcer healing drugs were associated with reduced likelihood of receiving anticoagulants, as were peptic ulcers, chronic gut disorders, anaemias, psychoses and poor compliance. Anticoagulant treatment was associated with several cardiovascular co-morbidities and drugs, possibly due to secondary care treatment. Nevertheless, only 56.5% of patients at very high risk of stroke were taking anticoagulants in 2003, whereas 38.2% of patients at low risk of stroke received anticoagulants. Conclusions: This study confirms previously observed trends of increasing AF prevalence and warfarin treatment. Many patients who may benefit from anticoagulation still do not receive it, whereas others at lower risk of stroke do. The lower likelihood of women receiving anticoagulants is of particular concern.

1 April 2003 in Heart
Verified
Journal Article
Open access
PDF file
SDS DeWilde
S DeWilde
ICI M Carey
I M Carey
SBS A Bremner
S A Bremner
NRN Richards
N Richards
SHS R Hilton
S R Hilton
DCD G Cook
D G Cook
Objective: To study trends in the use of lipid lowering drugs in the UK, and to assess which patient factors influence prescribing. Methods: Routinely collected computerised medical data were analysed from 142 general practices across England and Wales that provide data for the Doctors’ Independent Network database. Subjects included were people aged 35 years or more with treated ischaemic heart disease, averaging annually over 30 000. The temporal trend from 1994 to 2001 in prescription of lipid lowering drugs and daily statin dose and the odds ratios (ORs) for receiving a statin prescription in 1998 were examined. Results: Lipid lowering drug prescribing increased greatly over time, entirely because of statins, so that in 2001 56.3% of men and 41.1% of women with ischaemic heart disease received lipid lowering drugs. However, 33% of these patients were on a < 20 mg simvastatin daily equivalent. In 1998 the OR for receiving a statin fell from 1 at age 55–64 to 0.64 at 65–74 and 0.16 at 75–84 years. The age effect was similar in those without major comorbidity. Revascularised patients were much more likely to receive a statin than those with angina (OR 3.92, 95% confidence interval (CI) 3.57 to 4.31). Men were more likely to receive a statin than women (OR 1.62, 95% CI 1.54 to 1.71) but this difference disappeared after adjustment for age and severity of disease (OR 1.06). Geographical region had little effect but there was a very weak socioeconomic gradient. Conclusions: Although prescribing has increased, many patients who may benefit from lipid lowering drugs either do not receive it or are undertreated, possibly because of lack of awareness of the relative potency of the different statins. Patients with angina and the elderly are less likely to receive treatment that may prevent a coronary event.

22 November 2005 in Age and Ageing
Verified
Journal Article
Open access
PDF file
THTess Harris
Tess Harris
DCDerek G. Cook
Derek G. Cook
CVChristina R Victor
Christina R Victor
SDStephen DeWilde
Stephen DeWilde
CBCarole Beighton
Carole Beighton
Background: baseline physical health, disability and social support have been shown to predict depression onset, but findings for persistence are inconsistent. For onset and persistence of depression, the effect of changes in these risk factors over time is unclear. Objective: to use baseline factors and change in factors over time to predict onset and persistence of depression over a 2‐year period. Methods: a prospective cohort study with index assessment and 2-year follow-up of patients initially aged ≥65 years registered with two South London practices (n = 1,164). Depression was defined by a score >5/15 on the 15-item Geriatric Depression Scale. Associations between risk factors and onset and persistence of depression were analysed using multiple logistic regression. Results: the incidence of depression was 8.4%, while depression persisted amongst 61.2% of those depressed at baseline. Comparing onset and persistence suggested some common predictors: greater baseline depression score; and follow-up measures of poor general health and compromised social support. There was some evidence that pain and worsening disability were more important for depression onset. In contrast, low baseline belief in powerful others (health locus of control measure) predicted persistence only. Conclusion: focusing on older people with increasing disability, pain, physical ill-health and compromised social support should help in both the prevention and recognition of onset of later-life depression. In older people with depression, those with the highest symptom scores and low belief in powerful others at baseline were more likely to develop chronic symptoms and could be targeted for more intensive treatment and support.